Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 3 (2006), Issue 10 (October)

1. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
   Am J Ophthalmol, 142(4): 680-3. [Abstract] [Full-text]
2. Left colonic antegrade continence enema: experience gained from 19 cases.
   J Pediatr Surg, 41(10): 1750-4. [Abstract] [Full-text]
3. Glucocorticoid pretreatment suppresses chemokine expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention.
   J Pediatr Surg, 41(10): 1669-75. [Abstract] [Full-text]
4. Reversible attenuation of voltage of QRS complexes and P waves and shortening of QRS duration and QTc interval consequent to large perioperative intravenous fluid infusions.
   J Electrocardiol, 39(4): 415-8. [Abstract] [Full-text]
5. Recording lead V(4)R is associated to enhanced use of fibrinolytic therapy in acute myocardial infarction.
   J Electrocardiol, 39(4): 368.e1-5. [Abstract] [Full-text]
6. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
   Int J Radiat Oncol Biol Phys, 66(3): 731-7. [Abstract] [Full-text]
7. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study.
   Int J Cancer, 119(10): 2398-401. [Abstract] [Full-text]
8. Emergency medical services system changes reduce pediatric epinephrine dosing errors in the prehospital setting.
   Pediatrics, 118(4): 1493-500. [Abstract] [Full-text]
9. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
   Pediatrics, 118(4): e1244-9. [Abstract] [Full-text]
10. Risk reduction for adverse drug events through sequential implementation of patient safety initiatives in a children's hospital.
    Pediatrics, 118(4): e1124-9. [Abstract] [Full-text]
11. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Pediatrics, 118(4): e1139-45. [Abstract] [Full-text]
12. Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.
    Br J Cancer, 95(7): 848-52. [Abstract] [Full-text]
13. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
    Br J Cancer, 95(7): 817-21. [Abstract] [Full-text]
14. Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.
    Br J Cancer, 95(7): 862-8. [Abstract] [Full-text]
15. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    J Natl Cancer Inst, 98(19): 1397-405. [Abstract] [Full-text]
16. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics.
    Proc Natl Acad Sci U S A, 103(40): 14901-6. [Abstract] [Full-text]
17. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
    N Engl J Med, 355(14): 1432-44. [Abstract] [Full-text]
18. Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Blood, 108(8): 2540-4. [Abstract] [Full-text]
19. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.
    Blood, 108(8): 2827-35. [Abstract] [Full-text]
20. FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma.
    Blood, 108(8): 2720-5. [Abstract] [Full-text]
21. Phase II study of 3-week scheduling of irinotecan in combination with cisplatin in patients with advanced nonsmall-cell lung cancer.
    Am J Clin Oncol, 29(5): 503-7. [Abstract] [Full-text]
22. Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data.
    Am J Clin Oncol, 29(5): 490-4. [Abstract] [Full-text]
23. A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancer.
    Am J Clin Oncol, 29(5): 484-9. [Abstract] [Full-text]
24. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form.
    Curr Med Res Opin, 22(10): 1879-92. [Abstract] [Full-text]
25. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
    BMC Cancer, 6: 228. [Abstract] [Full-text]
26. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
    J Clin Oncol, 24(29): 4699-707. [Abstract] [Full-text]
27. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.
    J Clin Oncol, 24(29): 4731-7. [Abstract] [Full-text]
28. Risk of ischemic complications related to the intensity of triptan and ergotamine use.
    Neurology, 67(7): 1128-34. [Abstract] [Full-text]
29. Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 67(7): 1251-3. [Abstract] [Full-text]
30. The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen.
    Pediatr Blood Cancer, 47(7): 926-30. [Abstract] [Full-text]
31. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.
    JAMA, 296(14): 1749-56. [Abstract] [Full-text]
32. Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity.
    J Neurosci, 26(41): 10387-96. [Abstract] [Full-text]
33. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessment.
    Neurosurgery, 59(4): 925-33; discussion 933-4. [Abstract] [Full-text]
34. Use of heparin-coated stents in neurovascular interventional procedures: preliminary experience with 10 patients.
    Neurosurgery, 59(4): 812-21; discussion 821. [Abstract] [Full-text]
35. Information sources used by New South Wales cancer clinicians: a qualitative study.
    Intern Med J, 36(11): 711-7. [Abstract] [Full-text]
36. Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.
    Heart, 92(11): 1577-82. [Abstract] [Full-text]
37. An observational study of changes to long-term medication after admission to an intensive care unit.
    Anaesthesia, 61(11): 1087-92. [Abstract] [Full-text]
38. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.
    J Infect, 53(5): e215-8. [Abstract] [Full-text]
39. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.
    Plast Reconstr Surg, 118(6): 1441-6. [Abstract] [Full-text]
40. DHEA in elderly women and DHEA or testosterone in elderly men.
    N Engl J Med, 355(16): 1647-59. [Abstract] [Full-text]
41. Highly active antiretroviral therapy and hospital readmission: comparison of a matched cohort.
    BMC Infect Dis, 6: 146. [Abstract] [Full-text]
42. Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
    J Clin Oncol, 24(30): 4840-7. [Abstract] [Full-text]
43. Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.
    J Clin Oncol, 24(30): 4825-32. [Abstract] [Full-text]
44. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
    J Clin Oncol, 24(30): 4888-94. [Abstract] [Full-text]
45. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    J Clin Oncol, 24(30): 4808-17. [Abstract] [Full-text]
46. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.
    J Clin Oncol, 24(30): 4855-61. [Abstract] [Full-text]
47. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement.
    Kidney Int, 70(9): 1629-35. [Abstract] [Full-text]
48. Melanoma chemoprevention.
    J Am Acad Dermatol, 55(5): 849-61. [Abstract] [Full-text]
49. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    BMC Cancer, 6: 247. [Abstract] [Full-text]
50. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
    Clin Cancer Res, 12(20): 6133-43. [Abstract] [Full-text]
51. Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
    Clin Cancer Res, 12(20): 6094-9. [Abstract] [Full-text]
52. Treatment of mediastinal immature teratoma in a child with precocious puberty and Klinefelter's syndrome.
    Ann Thorac Surg, 82(5): 1906-8. [Abstract] [Full-text]
53. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma.
    Ann Thorac Surg, 82(5): 1802-7. [Abstract] [Full-text]
54. Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.
    Ann Thorac Surg, 82(5): 1692-7. [Abstract] [Full-text]
55. Expression of MxA protein in blood lymphocytes of children receiving anticancer chemotherapy.
    Pediatr Hematol Oncol, 23(8): 649-60. [Abstract] [Full-text]
56. Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols.
    Pediatr Hematol Oncol, 23(8): 631-7. [Abstract] [Full-text]
57. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Pediatr Hematol Oncol, 23(8): 625-9. [Abstract] [Full-text]
58. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses.
    Lancet, 368(9546): 1503-15. [Abstract] [Full-text]
59. Patients' knowledge regarding medication therapy and the association with health services utilization.
    Eur J Cardiovasc Nurs, 5(4): 311-6. [Abstract] [Full-text]
60. Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.
    Invest New Drugs, 25(1): 41-8. [Abstract] [Full-text]
61. Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.
    Invest New Drugs, 25(1): 69-75. [Abstract] [Full-text]
62. Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study.
    Invest New Drugs, 25(1): 57-62. [Abstract] [Full-text]
63. Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
    J Clin Oncol, 24(31): 5025-33. [Abstract] [Full-text]
64. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
    J Clin Oncol, 24(31): 4991-7. [Abstract] [Full-text]
65. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    J Clin Oncol, 24(31): 4983-90. [Abstract] [Full-text]
66. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
    J Clin Oncol, 24(31): 4976-82. [Abstract] [Full-text]
67. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
    J Clin Oncol, 24(31): 4971-5. [Abstract] [Full-text]
68. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
    J Clin Oncol, 24(31): 4956-62. [Abstract] [Full-text]
69. Significant link between sCD30 changes and HIV viremia in patients treated with HAART.
    J Med Virol, 78(12): 1513-9. [Abstract] [Full-text]
70. Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners.
    Eur J Pain, 11(1): 93-8. [Abstract] [Full-text]

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.